Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a22fb8607f3e2407

Jump to content

Sameridine

From Wikipedia, the free encyclopedia
Sameridine
Clinical data
Other namesLPB-139; LPB139
ATC code
  • none
Identifiers
  • N-ethyl-1-hexyl-N-methyl-4-phenylpiperidine-4-carboxamide
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC21H34N2O
Molar mass330.516 g·mol−1
3D model (JSmol)
  • O=C(N(CC)C)C2(c1ccccc1)CCN(CCCCCC)CC2
  • InChI=1S/C21H34N2O/c1-4-6-7-11-16-23-17-14-21(15-18-23,20(24)22(3)5-2)19-12-9-8-10-13-19/h8-10,12-13H,4-7,11,14-18H2,1-3H3 checkY
  • Key:TYWUGCGYWNSRPS-UHFFFAOYSA-N checkY
  (verify)

Sameridine (developmental code name LPB-139) is a 4-phenylpiperidine derivative that is related to the opioid analgesic drug pethidine (meperidine). It was under development as an anesthetic but was never marketed.[1]

Sameridine has an unusual pharmacological profile, being both a local anaesthetic and a μ-opioid partial agonist.[2] It is currently under development for use in surgical anasthesia, mainly administered by intrathecal infusion.[3] It produces less respiratory depression than morphine, even at a high dose, and produces no respiratory depression at a low dose.[4]

Sameridine is not currently a controlled drug, although if approved for medical use it will certainly be a prescription medicine, and it would probably be assigned to one of the controlled drug schedules in more restrictive jurisdictions such as Australia and the United States, especially if it were found to be addictive in animals.

References

[edit]
  1. "Sameridine". AdisInsight. 7 May 1999. Retrieved 8 June 2026.
  2. Modalen AO, Westman L, Arlander E, Eriksson LI, Lindahl SG (February 2003). "Hypercarbic and hypoxic ventilatory responses after intrathecal administration of bupivacaine and sameridine". Anesthesia and Analgesia. 96 (2): 570–5, table of contents. doi:10.1097/00000539-200302000-00049. PMID 12538214.
  3. Mulroy MF, Greengrass R, Ganapathy S, Chan V, Heierson A (April 1999). "Sameridine is safe and effective for spinal anesthesia: a comparative dose-ranging study with lidocaine for inguinal hernia repair". Anesthesia and Analgesia. 88 (4): 815–21. doi:10.1097/00000539-199904000-00025. PMID 10195530.
  4. Osterlund Modalen A, Arlander E, Eriksson LI, Lindahl SG (February 2001). "The effects on hypercarbic ventilatory response of sameridine compared to morphine and placebo". Anesthesia and Analgesia. 92 (2): 529–34. doi:10.1097/00000539-200102000-00046. PMID 11159263.
[edit]